BiolineRx Employee Directory
Biotechnology ResearchCentral District, Israel11-50 Employees
BioLineRx Ltd. is a pre-commercial biopharmaceutical company based in Modi'in Makkabbim Re'ut in the Central District of Israel, with operations in the United States. It pursues therapies for cancer and rare diseases, with a pipeline that includes investigational treatments for multiple myeloma, sickle cell disease, pancreatic cancer, and other solid tumors. The organization emphasizes end-to-end development and aims to move discoveries from the lab toward clinical use. It operates within the biotechnology research industry and focuses on oncology and rare diseases at the clinical development stage. In 2026, BioLineRx reported progress on GLIX1 for glioblastoma, including the first patient dosed in a Phase 1/2a trial and new data showing anti-tumor activity in preclinical studies. It also collaborates with Hemispherian AS on GLIX1 development.